Test Background Alkaline phosphatases (ALP) are membrane anchored dimeric enzymes. Specific phospholipases can cleave membrane bound ALP and produce free ALP in the serum. ALP consists of a family of four isoenzymes: (1) placental ALP (PLAP) (2) germ cell ALP (PLAP-like), (3) intestinal ALP (IAP), and (4) nonspecific tissue ALP (TNAP, also known as liver/bone/kidney ALP). The PLAP and PLAP-like enzymes share 98 % homology in their amino acid sequence and are both recognised by the PLAP assay. PLAP is synthesised in the placental syncytiotrophoblast starting after the 12th week of pregnancy. The PLAP-like enzyme is primarily synthesised in the testis, cervix and thymus. In healthy non-smoking adults, PLAP/PLAP-like enzyme activity represents less than 1 % of all serum ALP. Smoking causes elevation of the serum concentrations of the PLAP-like enzyme, limiting the value of PLAP-like enzyme as a tumour marker in smokers. Serum concentrations of PLAP-like enzyme return to the normal range after 1-2 months of smoking cessation. Ectopic expression of PLAP has been associated with cancer of the ovary, testis, lung and colorectal tract. The highest frequency of serum elevations of PLAP and PLAP-like enzyme are found in patients with ovarian (25 %-65.5 %) and testicular neoplasms 22 %-89 % (20-90 %).
Clinical Indications Germ cell tumour
Reference Range <100 mIU/L
Sample Required SST (gold top) preferred, serum (red top) accepted
Sample Volume 1 mL
Store at 2-8oC and send by first class post. If sample receipt will be delayed by >3 days, store samples at -20oC and send frozen.
Turnaround Time 4 weeks
Samples with total ALP activity >800 IU/L may react non-specifically in the PLAP assay.
Innotest enzyme immunoassay